The objectiv of this study was to determine the acute gastrointestinal effects caused by the consumption ofdrinking water coning graded levels ofadded copper. Sixty healy, adult women were randomly assigned to receive copper [Cu(II)] at four concentrations in their drinking water following a latin-square design. Each group (n -15) received tap water with no added copper, 1, 3, and 5 mg Cull of added copper sulfte for a 2-week study period, followed by 1 week of standard tap water. The subjecs recorded their water consumption and gaointestinal ymptoms daily on a special form. The avernge daily consumption of water was 1.64 liters per subject, regardless of the amount of copper added. Final serum copper, ceruloplamin, and liver enzymes were mesured in all subjects and were not di&rent from baseline con o. Twenty-one subjects (35%) recorded gastrointestinal disturbances someime during the study, 9 had dirrhea,. some with abdominal pain and vomiting and 12 subjects presented abdominal pain, nausea, or vomiting. There was no association between copper levels in drinking water and diarrhea.
Exposure to copper results almost exclusively from food and water intake, although small fractions come via inhalation and via skin contact with copper-containing substances (1-7). Intakes of copper at doses that exceed physiological requirements are normally controlled by efficient homeostatic mechanisms (8, 9) . Acute copper toxicity is infrequent in humans and is usually the consequence of consumption of contaminated foodstuffs or beverages, including drinking water, or from accidental or deliberate ingestion of high quantities of copper salts. Acute symptoms include excessive salivation, epigastric pain, nausea, vomiting, and diarrhea (10) (11) (12) . Intravascular hemolytic anemia, acute hepatic failure, acute tubular renal failure, shock, coma, and death have been observed in severe copper poisoning (5, 7) . Anecdotal reports from isolated occur- rences suggest that the consumption of beverages or drinking water contaminated with copper results in abdominal pain, nausea, vomiting, and diarrhea in humans. However, the threshold for gastrointestinal symptoms of copper in drinking water has not been precisely established (13) 
Materials and Methods
This study was double-blind for the subjects and prospective in nature. Sixty healthy adult women were randomized into four copper groups, ingesting 0, 1, 3, and 5 mg of added ionic copper (as CuSO4. 5H20) per liter of tap water. The corresponding concentrations of sulfate anion were 0, 1.5, 4.5 , and 7.6 mg/l. Total duration of the study was 11 weeks, which were divided into four 2-week study periods, with 1 
Results
Serum copper levels at baseline were found to be within the normal range for women (65-185 pg/dl). The analyzed liver enzymes in all subjects were also within normal ranges. The levels of serum copper, ceruloplasmin, AAT, ALAT, and GGT remained within normal limits of the baseline both at the end of first period and at the end of the study ( Weeks of follow-up and 5 mg Cu/l. On discontinuing consumption of copper water, the symptoms persisted in subjects ingesting 0 mg Cu/l and disappeared in all subjects consuming drinking water with copper added. Symptoms reappeared in 23 of 27 episodes while subjects consumed drinking water with 3 and 5 mg Cull. Nongastrointestinal symptoms induded seven subjects with headaches and six with increased salivation when they ingested water with 3 and 5 mg Cu/l; in contrast, three and two subjects exhibited these symptoms when they ingested water with 0 and 1 mg Cu/l, respectively (Fisher's Exact test, NS). Figure 2 shows the gastrointestinal morbidity over time, independent of copper concentration in water, expressed as the ratio of episodes in each of the weeks relative to episodes occurring in the first week. Six of the 12 episodes of diarrhea that occurred throughout the study were presented during the first week of study; afterwards a significant decline was noted (X2 =19.1, p<0.008). The response followed a polynomial function as noted in Figure 2 , suggesting that tolerance was induced over time. In contrast, the time distribution of abdominal pain, nausea, and vomiting was consistent throughout the study (seven in (10) (11) (12) . Hepatic damage has been reported when copper is ingested chronically at extremely high intake, >30 mg/day (16) (17) (18) . In our study, the average ingestion of 1.8 14 days did not produce changes in liver enzymes. Throughout the study, the three liver enzymes measured remained stable and within normal ranges. These results were expected due to the short duration of the study and levels of copper intake.
The mean taste threshold for ionic copper is approximately 2.6 mg/l in distilled water (19) . In tap water the taste threshold is slightly higher (2.5-3.0 mg Cu/l) (20) . Therefore, concentrations at 3 mg Cu/l or above would be likely detected in the tap water of Santiago. Thus, gastrointestinal symptoms would be related, in part, to the astringent and bitter taste of the water.
The average dietary intake of copper among the study population, based on a 24-hr recall interview, was 1.7 mg Cu/day. This quantity is found within the range established by the "estimated safe and adequate daily dietary intakes" (ESADDI; 1.5-3 mg/day for adults) (21) and is similar to that reported by the International Atomic Energy Agency (IAEA) in studies of 47 countries that demonstrated that the majority of the countries have an average dietary intake ofcopper dose to 1.5 mg/day (22.
Tap water was not a significant source of dietary copper, as the natural concentration of this micronutrient was only 0.02 mg/l. As expected, the overall intake of copper increased when the subjects were introduced to water with added copper. When consuming water with 1 mg Cu/l, the subjects received 3.5 mg Cu/day (1.8 mg of Cu from the water and 1.7 mg Cu from their diet). This is higher than the upper value of the ESADDI. With the level of 3 mg Cu/l in water, total copper consumption was 7.1 mg/day, which is almost double the ESADDI. At a level of 5 mg Cu/l, the total consumption of copper was 9.8 mg/day, approximately three times the upper value of ESADDI. However, all intake levels were below the limit of 0.5 mg of copper/kg body weight per day defined as precautionary intake level (maximum tolerable daily copper intake) by the Joint Food and Agricultural Organization of the United Nations/World Health Organization (WHO) Expert Committee on Food Additives (23) in the absence of an NOAEL (no-observed-adverse-effect level). Thus, our study indicates that acute reversible gastrointestinal symptoms occur below the limit provisionally established as safe in terms of chronic effects.
The results of our study show that there is no association between copper levels in drinking water and diarrhea with or without vomiting or abdominal pain in the range of 0-5 mg/l. At 3 mg Cu/l ofwater, a significant increase in reported nausea, abdominal pain, or vomiting occurs. Close to a third of the subjects presented mild gastrointestinal disturbances during the study. Nine women (15%) presented 12 episodes of diarrhea, and the remaining 12 (20%) suffered from nausea, abdominal pain, or vomiting. It is important to recognize that 8 of the 12 episodes of diarrhea were reported within the first 2 weeks of the study. This was not the case with nausea and abdominal pain, which were fairly consistent throughout the duration of the study. The etiology of the diarrhea could not be ascribed to other factors because the same subjects did not present diarrhea when they took the water without added copper.
To explain the distinct behavior in the frequency ofdiarrhea according to the period of the study, various hypotheses arise: 1) a possible placebo effect, 2) the subjects stopped consuming the copper water, or 3) there was an adaptation among the subjects to the higher copper exposure. The placebo effect among the population in this study could have been provoked by psychological concerns that occasionally occur when participating in experimental studies. However, it is not likely that a placebo effect can explain the diarrhea because the frequency of other symptoms such as abdominal pain, nausea, and vomiting had a different distribution. The fact that the group consuming water without added copper presented only two episodes of gastrointestinal symptomatology does not support the placebo hypothesis either. In fact, the frequency of gastrointestinal symptoms observed in this study is comparable to the results of a previous study in Santiago indicating that apparently healthy women self-report 0.22 gastrointestinal episodes per subject per year (24). Our rate is slighdy higher (0.54), and this could be explained by the fact that subjects in this study were asked to report symptoms and thus may have had a greater sensitivity to symptoms. We purposely asked them to record any discomfort they felt. Compliance was monitored, but we could not be certain that they prepared and consumed the water as instructed. Although the population studied was highly motivated to fulfill their obligation to drink the copper water as instructed, it must be noted that in all groups participant consumption of the experimental water decreased from 1.81 3 weeks after the report of the illness, while in the first study the samples were collected 7 months after the manifestation of illness.
Two other published studies (11, 12) have serious methodological problems, such as not taking certain factors into account, and so they do not permit a definitive statement to be made about the gastrointestinal effects of high concentrations of copper in tap water. In our study we controlled for factors such as diet, alcohol consumption, and presence of menstruation, and because randomization included a no-copper-added group, we could control for confounders. In our study, 25% of the subjects presented gastrointestinal symptoms when they abruptly changed the consumption of potable water from their homes (0.02 mg Cu/l) for water with 1 mg Cu/l or more. However, the presence of diarrhea tended to disappear over time. No association between copper concentration and incidence of diarrhea was observed.
The limit of 2 mg Cu/l, the provisional guideline value for copper in drinking water suggested by the World Health Organization as safe for human consumption, is below the 3 mg/l that we tested. Another controlled study in infants carried out by our group demonstrated that the ingestion of water with 2 mg Cu(II)/l did not produce more episodes ofdiarrhea than the consumption of water with <0.1 mg Cu(II)Q1 (25) . Clearly, this study only deals with symptomatology in adults, but infants and children may perhaps be affected to a greater degree, as suggested in other studies (12. Therefore, firther investigation in this area is warranted so that the appropriate and safe levels for children can be determined.
In conclusion, our study demonstrates that copper in drinking water, as ionized copper, showed no association between copper levels and diarrhea, although at concentrations >3 mg/l copper is associated with an increase in gastrointestinal symptoms (nausea, abdominal pain, or vomiting) above baseline. This level of ionic copper in drinking water may be associated with higher total copper content, as several copper species found in drinking water are not fully soluble. Thus, drinking water with higher copper concentration may be well tolerated. Further studies are required to determine the population-based copper concentration threshold for different gastrointestinal symptoms and the specific response to copper species actually found in drinking water.
